These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10872183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
    Ferraris JR, Pasqualini T, Alonso G, Legal S, Sorroche P, Galich AM, Jasper H, Deflazacort Study Group.
    Pediatr Nephrol; 2007 May; 22(5):734-41. PubMed ID: 17294225
    [Abstract] [Full Text] [Related]

  • 5. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G, Riboldi A, Imbimbo B, Torresin A, Milani S.
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation.
    Ferraris JR, Fainstein Day P, Gutman R, Granillo E, Ramirez J, Ruiz S, Pasqualini T.
    J Pediatr; 1992 Nov; 121(5 Pt 1):809-13. PubMed ID: 1432436
    [Abstract] [Full Text] [Related]

  • 9. Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
    Ferraris JR, Pasqualini T, Legal S, Sorroche P, Galich AM, Pennisi P, Domene H, Jasper H.
    Pediatr Nephrol; 2000 Jul; 14(7):682-8. PubMed ID: 10912543
    [Abstract] [Full Text] [Related]

  • 10. Deflazacort in juvenile chronic arthritis.
    Loftus JK, Reeve J, Hesp R, David J, Ansell BM, Woo PM.
    J Rheumatol Suppl; 1993 Apr; 37():40-2. PubMed ID: 8501751
    [Abstract] [Full Text] [Related]

  • 11. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
    Aicardi G, Milani S, Imbimbo B, Vignolo M, Di Battista E, Gusmano R, Terragna A, Cordone G, Cottafava F, Coppo R.
    Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K, Storm T, van Wowern N, Daugaard H, Egfjord M, Lewin E, Brandi L.
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [Abstract] [Full Text] [Related]

  • 13. Weight-/height-related bone mineral density is not reduced after renal transplantation.
    Klaus G, Paschen C, Wüster C, Kovacs GT, Barden J, Mehls O, Schärer K.
    Pediatr Nephrol; 1998 Jun; 12(5):343-8. PubMed ID: 9686950
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G, Abdi Ali L, Shams Eddin S, Coppini A, Cavalieri F, Campostrini L, Sacco S, Bucci M, Cirino G, Rossini M.
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [Abstract] [Full Text] [Related]

  • 16. Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants.
    Ellis D.
    Pediatr Nephrol; 2000 Jul; 14(7):689-94. PubMed ID: 10912544
    [Abstract] [Full Text] [Related]

  • 17. Development of growth and body mass index after pediatric renal transplantation.
    Vester U, Schaefer A, Kranz B, Wingen AM, Nadalin S, Paul A, Malagò M, Broelsch CE, Hoyer PF.
    Pediatr Transplant; 2005 Aug; 9(4):445-9. PubMed ID: 16048595
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Deflazacort: a glucocorticoid with few metabolic adverse effects but important immunosuppressive activity.
    Gonzalez-Perez O, Luquin S, Garcia-Estrada J, Ramos-Remus C.
    Adv Ther; 2007 Aug; 24(5):1052-60. PubMed ID: 18029332
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.